They revealed that the cancer cells adjusted their glucose metabolic status by mTOR pathway regulating the expression of molecule associated with glucose and lactate uptake and acquired the resistance to hypoxia condition induced by anti-angiogenic therapy. This evidence concerns the gene MTOR and cancer.